R87.81
High risk human papillomavirus (HPV) DNA test positive from female genital organs
Clinical Classification Guidelines
Excludes Type 1
- anogenital warts due to human papillomavirus (HPV) (A63.0)
- condyloma acuminatum (A63.0)
Medical Intelligence & Overview
A positive test for high risk human papillomavirus (HPV) DNA from female genital organs indicates the presence of a type of HPV associated with a higher likelihood of developing cervical and other genital cancers. This condition is identified through specific screening tests designed to detect the DNA of high-risk HPV strains. Recognizing a positive result is an essential step in monitoring and managing health risks related to HPV infections.
Causes & Symptoms
Clinical Causes: Transmission through sexual contact with an infected person Multiple sexual partners increasing exposure risk Weakened immune system reducing the body's ability to clear HPV infection Age-related factors, as younger women and those over 30 may have different risk levels Poor genital hygiene practices Previous HPV infections that have persisted
Key Symptoms: Often asymptomatic, meaning no noticeable symptoms Abnormal Pap smear results Genital warts (less common with high-risk strains but possible) Persistent irritation or itching in the genital area Unusual vaginal bleeding or discharge
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves laboratory testing following an abnormal Pap smear or when screening for HPV. The high risk HPV DNA test is performed on cells taken from the female genital organs, often during a pelvic examination. The test detects the presence of DNA from high-risk HPV strains associated with cervical and other cancers. Additional examinations, such as colposcopy, may be recommended to investigate any abnormal findings and assess the health of the cervical tissue.
Treatment Protocols: Regular follow-up screenings to monitor for cellular changes Colposcopic examination to closely examine the cervix Removal of abnormal cells if precancerous changes are detected, through procedures like cryotherapy, loop electrosurgical excision procedure (LEEP), or laser therapy Vaccination against HPV for long-term prevention, if appropriate Adopting safer sexual practices to reduce transmission risk Lifestyle modifications to support immune health
Clinical Advice & FAQs
Billing Guidance
Is R87.81 a billable ICD-10 code?
Yes, R87.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R87.81?
Clinical documentation must specify the nature of High risk human papillomavirus (HPV) DNA test positive from female genital organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference